Results 211 to 220 of about 387,738 (257)

Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy. [PDF]

Clinicoecon Outcomes Res
Panatto D, Bellone M, Castello L, Zanetta L, Piccolo A.   +4 more
europepmc   +1 more source

A CRISPR activation screen identifies CH25H as a restriction factor against influenza viruses by targeting accessible cholesterol. [PDF]

Emerg Microbes Infect
Huang J, Ma K, Ding S, Wang Y, Xiong J, Yi J, Zhang J, He Z, Huang L, Ren X, Zhou J, Chen X, Liu L, Qi W, Wang S, Liao M.   +15 more
europepmc   +1 more source

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults. [PDF]

J Virol
van Pul L, Rosendahl Huber SK, Jacobi R, Hendriks M, van Schuijlenburg R, van Sleen Y, Bijvank E, de Wit J, van Beek J.   +8 more
europepmc   +1 more source

Frequency and Demographic Patterns of SARS-CoV-2 and Influenza Virus Infections in Khuzestan: A Retrospective Observational Study (2021-2023). [PDF]

Adv Virol
Nasimzadeh S, Mohammadpour Fard R, Ghasemi S, Marhemati F, Movahedi M, Rashtizadeh B, Darvishi F, Hesam S, Makvandi M, Khodadadi A, Torabizadeh M, Saki N, Balar N, Rashno M.   +13 more
europepmc   +1 more source

Correction to "Burden of Severe Disease Associated With Influenza, SARS-CoV-2 and RSV in Spain During the 2024-2025 Winter Season." [PDF]

Influenza Other Respir Viruses
europepmc   +1 more source

Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization. [PDF]

J Infect Dis
Villafuerte D, Fall A, Akin E, Werner AP, Pinsley M, Vue Y, Abdullah O, Zhuang TX, Norton JM, Rothman RE, Fenstermacher KZJ, Morris CP, Klein E, Pekosz A, Mostafa HH.   +14 more
europepmc   +1 more source

Influenza Vaccination Trends Among Children and Adolescents, 2017-2023.

JAMA Netw Open
Rane MS, Gopalan G, Nahmias J, Rinke ML, Teasdale CA.   +4 more
europepmc   +1 more source